Drug Profile
Research programme: angiogenesis inhibitors of HIF-1 - Cell Therapeutics
Alternative Names: Angiogenesis inhibitors research programme - Cell TherapeuticsLatest Information Update: 21 Jul 2008
Price :
$50
*
At a glance
- Originator Cell Therapeutics
- Class Small molecules
- Mechanism of Action Angiogenesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Solid tumours
Most Recent Events
- 19 Jul 2007 Preclinical development is ongoing
- 01 Sep 2005 This programme is still in active development
- 07 Jan 2004 Novuspharma has merged with and into Cell Therapeutics